Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Intangibles (2017 - 2025)

Organogenesis Holdings has reported Intangibles over the past 9 years, most recently at $9.1 million for Q4 2025.

  • Quarterly results put Intangibles at $9.1 million for Q4 2025, down 26.65% from a year ago — trailing twelve months through Dec 2025 was $9.1 million (down 26.65% YoY), and the annual figure for FY2025 was $9.1 million, down 26.65%.
  • Intangibles for Q4 2025 was $9.1 million at Organogenesis Holdings, down from $9.9 million in the prior quarter.
  • Over the last five years, Intangibles for ORGO hit a ceiling of $29.4 million in Q1 2021 and a floor of $9.1 million in Q4 2025.
  • Median Intangibles over the past 5 years was $17.7 million (2023), compared with a mean of $18.4 million.
  • Biggest five-year swings in Intangibles: surged 47.03% in 2021 and later fell 26.65% in 2025.
  • Organogenesis Holdings' Intangibles stood at $25.7 million in 2021, then fell by 19.02% to $20.8 million in 2022, then fell by 23.66% to $15.9 million in 2023, then dropped by 21.44% to $12.5 million in 2024, then dropped by 26.65% to $9.1 million in 2025.
  • The last three reported values for Intangibles were $9.1 million (Q4 2025), $9.9 million (Q3 2025), and $10.8 million (Q2 2025) per Business Quant data.